BR9909868A - Ascorbato de paroxetina - Google Patents

Ascorbato de paroxetina

Info

Publication number
BR9909868A
BR9909868A BR9909868-7A BR9909868A BR9909868A BR 9909868 A BR9909868 A BR 9909868A BR 9909868 A BR9909868 A BR 9909868A BR 9909868 A BR9909868 A BR 9909868A
Authority
BR
Brazil
Prior art keywords
paroxetine ascorbate
paroxetine
ascorbate
useful
treatment
Prior art date
Application number
BR9909868-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9909868A publication Critical patent/BR9909868A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9909868-7A 1998-04-25 1999-04-23 Ascorbato de paroxetina BR9909868A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound
PCT/GB1999/001244 WO1999055698A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate

Publications (1)

Publication Number Publication Date
BR9909868A true BR9909868A (pt) 2000-12-19

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909868-7A BR9909868A (pt) 1998-04-25 1999-04-23 Ascorbato de paroxetina

Country Status (20)

Country Link
EP (1) EP1089995A1 (id)
JP (1) JP2002513019A (id)
KR (1) KR20010042977A (id)
CN (1) CN1297448A (id)
AP (1) AP2000001963A0 (id)
AU (1) AU3618499A (id)
BG (1) BG104940A (id)
BR (1) BR9909868A (id)
CA (1) CA2330055A1 (id)
EA (1) EA200001104A1 (id)
GB (1) GB9808896D0 (id)
HU (1) HUP0102116A3 (id)
ID (2) ID26654A (id)
IL (1) IL139081A0 (id)
NO (1) NO20005352L (id)
PL (1) PL343677A1 (id)
SK (1) SK15912000A3 (id)
TR (1) TR200003084T2 (id)
WO (1) WO1999055698A1 (id)
ZA (1) ZA200005912B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
JP4508646B2 (ja) * 2002-01-09 2010-07-21 エミスフェアー・テクノロジーズ・インク 4−[(4−クロロ−2−ヒドロキシベンゾイル)アミノ]ブタン酸ナトリウムの多形体
CN110607554B (zh) * 2018-10-30 2024-03-22 中国科学院化学研究所 一种制备药物或药物中间体单晶或无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
PL343677A1 (en) 2001-08-27
NO20005352D0 (no) 2000-10-24
JP2002513019A (ja) 2002-05-08
SK15912000A3 (sk) 2001-04-09
TR200003084T2 (tr) 2001-02-21
AP2000001963A0 (en) 2000-12-31
CN1297448A (zh) 2001-05-30
ZA200005912B (en) 2001-12-19
NO20005352L (no) 2000-10-24
WO1999055698A1 (en) 1999-11-04
ID26654A (id) 2001-01-25
HUP0102116A2 (hu) 2002-05-29
KR20010042977A (ko) 2001-05-25
EP1089995A1 (en) 2001-04-11
AU3618499A (en) 1999-11-16
HUP0102116A3 (en) 2002-12-28
IL139081A0 (en) 2001-11-25
BG104940A (bg) 2001-09-28
GB9808896D0 (en) 1998-06-24
EA200001104A1 (ru) 2001-04-23
ID26083A (id) 2000-11-23
CA2330055A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
MX9201419A (es) Derivados de benzo isoxazol-piperidina.
IT244967Y1 (it) Ortesi dinamica per il trattamento conservativo dell'instabilita'femoro-rotulea del ginocchio
ES2191102T3 (es) Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
TR200000059T2 (tr) Piridin türevleri
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
FI972919A (fi) Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
BR9909868A (pt) Ascorbato de paroxetina
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO990450D0 (no) Behandling av sinnslidelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
DE69917445D1 (de) Reinigung von carboxaldehyd
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
AP2000001958A0 (en) Paroxetine 10-camphorsulfornate for treatment of CNS disorders.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]